The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.

HEMO HEMOGENYX PHARMACEUTICALS PLC ORD GBP0.01




 Page 1 of 3

| 1 | 2 | 3 | Next

Time/Date Code Headline Source Impact
11:39 27-Jun-2018 HEMO Result of AGM RNS -0.73% Down
07:00 08-Jun-2018 HEMO Investor presentation RNS -3.12% Down
18:05 05-Jun-2018 HEMO Posting of Annual Report & Notice of AGM RNS -8.17% Down
07:00 14-May-2018 HEMO Development Agreement RNS +26.36% Up
07:00 08-May-2018 HEMO Research Collaboration with Rockefeller University RNS +10.56% Up
16:23 30-Apr-2018 HEMO Final Results RNS +3.84% Up
17:15 11-Apr-2018 HEMO Director/PDMR Shareholding RNS -1.98% Down
07:00 03-Apr-2018 HEMO Directorate Change RNS +3.01% Up
11:05 14-Mar-2018 HEMO Second Price Monitoring Extn RNS -14.79% Down
11:00 14-Mar-2018 HEMO Price Monitoring Extension RNS -14.79% Down
07:00 13-Mar-2018 HEMO Collaboration with major US biotechnology company RNS -16.16% Down
07:00 06-Mar-2018 HEMO Advisory Board Appointment RNS -21.62% Down
07:00 01-Mar-2018 HEMO Align Research Initiation of Coverage RNS +18.16% Up
16:40 27-Feb-2018 HEMO Second Price Monitoring Extn RNS +57.39% Up
16:35 27-Feb-2018 HEMO Price Monitoring Extension RNS +57.39% Up
14:17 26-Feb-2018 HEMO Stmnt re Share Price Movement RNS +130.12% Up
07:00 12-Feb-2018 HEMO Director/PDMR Shareholding RNS -1.16% Down
07:00 07-Feb-2018 HEMO Director/PDMR Shareholding RNS -4.49% Down
07:00 11-Jan-2018 HEMO Hemogenyx Welcomes N.Y. Lt. Governor to its Labs RNS -1.04% Down
12:16 07-Dec-2017 HEMO Result of AGM RNS -2.33% Down

 Page 1 of 3

| 1 | 2 | 3 | Next



Price changes are calculated on the basis of the following formula: [ avg(x) - avg(y)] / avg(y) where:
x = instrument's 7 closing prices after the news has been released
y = instrument's latest 7 closing prices before the news was released, including the day of the release of the news

Please note that the news releases are only one of the multiple factors that could have had an impact on the change in the security’s price over the time period analysed by the News Analysis tool. Where data are insufficient the graph does not show any price change and the table below the graph displays a blank “ - “ next to the line indicating the RNS issue.




Company Information
Company website http://www.he...ogenyx.co...
Company address 5 Fleet Place, London, EC4M 7RD, United Kingdom
FTSE ICB sector Pharmaceuticals & Biotechnology
FTSE ICB subsector Biotechnology
Company market cap, £m* 11.70
Admission date 09 Nov 2015
*The company market capitalization reflects the London listed element of Ordinary and Preference shares only and is approximate. Data provided by FTSE Russell.

Security Information
FTSE index -
Market Main Market
Market identifier code (MIC) XLON
Trading service SETSqx
Trading segment SSQ3
Listing category Standard Shares
Country of share register GB
ISIN GB00BYX3WZ24
SEDOL BYX3WZ2
Exchange market size 30,000
Security market cap, £m 11.70
*The market capitalisation of the security reflects data from previous trading day.


HEMOGENYX share news analysis (HEMO)